Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Canadian approval for one- and three-month Eligard products

March 8, 2004

Yakult Honsha files Japanese import application for oxaliplatin

March 8, 2004

Ultrafine completes scale-up of PPA-605 and PPA-904

March 8, 2004

Boehringer Ingelheim claims new TK inhibitors for cancer and other proliferative disorders

March 5, 2004

New KSP inhibitors in early development at Cytokinetics

March 5, 2004

BMS researchers identify novel VEGFR2 and FGFR1 inhibitors

March 5, 2004

Improved therapeutic index for AP-5280 in vitro and in vivo as compared to carboplatin

March 5, 2004

Hudson Health Sciences licenses novel radiosensitizer IPdR

March 5, 2004

Chiron and Xoma collaborate to develop therapeutic antibodies for cancer

March 5, 2004

Novel CDK inhibitor with in vitro antiapoptotic activity described

March 4, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...